Class information for:
Level 2: CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HHV 6

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
630 13104 36.1 80%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
150 59286 VIROLOGY//CYTOMEGALOVIRUS//EPSTEIN BARR VIRUS

Classes in level below (level 1)


ID, lev. below Publications Label for level below
231 3781 CYTOMEGALOVIRUS//VALGANCICLOVIR//GANCICLOVIR
342 3549 HUMAN CYTOMEGALOVIRUS//HCMV//US28
2822 2064 CONGENITAL INFECTION//CONGENITAL CYTOMEGALOVIRUS INFECTION//CYTOMEGALOVIRUS
4377 1721 HHV 6//HUMAN HERPESVIRUS 6//EXANTHEM SUBITUM
12752 820 MURINE CYTOMEGALOVIRUS//MCMV//LY49H
13453 772 CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS
32744 103 IG LEVELS//LEUKEMIC CHILDREN//PROGNOSIS SURVIVAL
33190 96 C T USPHS//NULL CELLS//VIRUS THERMOSTABILITY
33897 83 VEGETABLE CELLS//ANAT PATHOL SERV 2//CICLO FORMAT ANAT PATOL CITOL
34947 58 GROSSING//MARGIN INKING//RESECTION LIMITS
34956 57 RHEUMATOID SYNOVIAL MEMBRANE//ANTITUMORAL IMMUNE RESPONSE//ANTITUMORAL IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 CYTOMEGALOVIRUS Author keyword 1116 45% 14% 1845
2 HUMAN CYTOMEGALOVIRUS Author keyword 451 64% 3% 443
3 HHV 6 Author keyword 376 78% 2% 247
4 HUMAN HERPESVIRUS 6 Author keyword 353 70% 2% 291
5 VALGANCICLOVIR Author keyword 224 75% 1% 164
6 HCMV Author keyword 195 63% 2% 198
7 CMV Author keyword 167 38% 3% 354
8 CONGENITAL INFECTION Author keyword 153 58% 1% 179
9 GANCICLOVIR Author keyword 138 34% 3% 329
10 CONGENITAL CYTOMEGALOVIRUS INFECTION Author keyword 138 89% 0% 63

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 CYTOMEGALOVIRUS 1116 45% 14% 1845 Search CYTOMEGALOVIRUS Search CYTOMEGALOVIRUS
2 HUMAN CYTOMEGALOVIRUS 451 64% 3% 443 Search HUMAN+CYTOMEGALOVIRUS Search HUMAN+CYTOMEGALOVIRUS
3 HHV 6 376 78% 2% 247 Search HHV+6 Search HHV+6
4 HUMAN HERPESVIRUS 6 353 70% 2% 291 Search HUMAN+HERPESVIRUS+6 Search HUMAN+HERPESVIRUS+6
5 VALGANCICLOVIR 224 75% 1% 164 Search VALGANCICLOVIR Search VALGANCICLOVIR
6 HCMV 195 63% 2% 198 Search HCMV Search HCMV
7 CMV 167 38% 3% 354 Search CMV Search CMV
8 CONGENITAL INFECTION 153 58% 1% 179 Search CONGENITAL+INFECTION Search CONGENITAL+INFECTION
9 GANCICLOVIR 138 34% 3% 329 Search GANCICLOVIR Search GANCICLOVIR
10 CONGENITAL CYTOMEGALOVIRUS INFECTION 138 89% 0% 63 Search CONGENITAL+CYTOMEGALOVIRUS+INFECTION Search CONGENITAL+CYTOMEGALOVIRUS+INFECTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CMV INFECTION 734 80% 4% 460
2 EXANTHEM SUBITUM 707 87% 3% 351
3 HHV 6 430 81% 2% 258
4 CMV DISEASE 430 84% 2% 235
5 MURINE CYTOMEGALOVIRUS 395 60% 3% 433
6 PREEMPTIVE THERAPY 368 78% 2% 240
7 HUMAN HERPESVIRUS 6 344 50% 4% 492
8 ORAL GANCICLOVIR 340 72% 2% 267
9 PP65 ANTIGENEMIA 315 88% 1% 148
10 HUMAN HERPESVIRUS 6 INFECTION 300 71% 2% 243

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TRANSPLANT INFECTIOUS DISEASE 12 11% 1% 107
2 CLINICAL AND DIAGNOSTIC VIROLOGY 3 12% 0% 25

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The pathogenesis of human cytomegalovirus 2015 8 80 86%
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection 2007 289 67 97%
The "Silent" Global Burden of Congenital Cytomegalovirus 2013 55 186 97%
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection 2010 164 114 89%
Classification of HHV-6A and HHV-6B as distinct viruses 2014 16 122 98%
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection 2007 214 26 100%
Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review 2014 15 64 91%
Immunobiology of Human Cytomegalovirus: from Bench to Bedside 2009 163 277 74%
How I treat cytomegalovirus in hematopoietic cell transplant recipients 2009 131 98 87%
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? 2015 2 90 83%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SERV VIROL 28 20% 1.0% 125
2 MED VIROL EPIDEMIOL VIRAL DIS 23 51% 0.2% 32
3 SPERIMENTALI RIC 22 48% 0.3% 34
4 ST ORSOLA GEN HOSP 21 75% 0.1% 15
5 INFECT DIS MICROBIOL TRANSLAT 18 33% 0.4% 46
6 SC OSTETRICIA GINECOL 17 100% 0.1% 8
7 KLIN MOL VIROL 15 26% 0.4% 48
8 ST ORSOLA MALPIGHI GEN HOSP 14 55% 0.1% 18
9 AREA TR IANTOL 13 55% 0.1% 16
10 VACCINE GENE THER Y 13 18% 0.5% 64

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000011761 HERPES SIMPLEX VIRUS//VARICELLA ZOSTER VIRUS//HERPES ZOSTER
2 0.0000008533 UVEITIS//CYTOMEGALOVIRUS RETINITIS//OCULAR IMMUNOLOGY AND INFLAMMATION
3 0.0000007995 KAPOSIS SARCOMA//HUMAN HERPESVIRUS 8//KSHV
4 0.0000007693 NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV
5 0.0000007161 LUNG TRANSPLANTATION//BRONCHIOLITIS OBLITERANS SYNDROME//CHRONIC LUNG ALLOGRAFT DYSFUNCTION
6 0.0000006888 HLA G//KIR//NKG2D
7 0.0000006850 LIPODYSTROPHY//HIV ASSOCIATED NEPHROPATHY//LIPOATROPHY
8 0.0000005221 BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
9 0.0000005204 EPIDEMIC KERATOCONJUNCTIVITIS//HIGH LEVEL DISINFECTION//OPHTHALMOLHOWE
10 0.0000003940 IMMUNOSENESCENCE//NUTRIENT MIXTURE//IMMUNITY & AGEING